Trifluoperazine
Trifluoperazine is a potent dopamine D2 receptor antagonist (IC50 = 1.2 nM) used in schizophrenia research. This phenothiazine neuroleptic is applied in in vitro binding assays and in vivo studies to investigate dopaminergic signaling and antipsychotic mechanisms.
Product Specifications
CAS Number
117-89-5
Product Name Alternative
D2, DopamineReceptor, Dopamine, Dopamine Receptor, Beta Receptor, Cluster of differentiation 243, CD243, Calmodulin-dependent kinases, Calmodulin-dependent protein kinases, CaMK, anticancer, antipsychotic, Autophagy, Adrenergic Receptor, AdrenergicReceptor, ABCB1, morphogenesis, InfluenzaVirus, Multidrug resistance protein 1, Influenza Virus, inhibit, Inhibitor, NUPR1, MDR1, schizophrenia, P-glycoprotein, P-gp, Pgp, P-gp (P-glycoprotein), trifluoroperazine, Trifluoperazine
Field of Research
Cell Biology, Infectious Disease & Virology, Neuroscience, Pharmacology & Drug Discovery
Purity
98.30% (May vary between batches)
Solubility
DMSO:242 mg/mL (593.87 mM)
Smiles
CN1CCN (CCCN2C3=C (SC4=C2C=C (C=C4) C (F) (F) F) C=CC=C3) CC1
Molecular Formula
C21H24F3N3S
Molecular Weight
407.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog